1. Home
  2. CRSP vs TREX Comparison

CRSP vs TREX Comparison

Compare CRSP & TREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG

HOLD

Current Price

$54.91

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Logo Trex Company Inc.

TREX

Trex Company Inc.

HOLD

Current Price

$49.72

Market Cap

3.9B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRSP
TREX
Founded
2013
1996
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
3.9B
IPO Year
2016
1998

Fundamental Metrics

Financial Performance
Metric
CRSP
TREX
Price
$54.91
$49.72
Analyst Decision
Buy
Buy
Analyst Count
17
17
Target Price
$70.29
$49.53
AVG Volume (30 Days)
1.6M
1.8M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.58
Revenue
$289,590,000.00
$1,174,267,000.00
Revenue This Year
$807.72
$5.09
Revenue Next Year
$172.52
$6.24
P/E Ratio
N/A
$86.21
Revenue Growth
9169.85
1.98
52 Week Low
$44.12
$29.77
52 Week High
$78.48
$68.78

Technical Indicators

Market Signals
Indicator
CRSP
TREX
Relative Strength Index (RSI) 53.13 66.79
Support Level $50.17 $49.55
Resistance Level $60.10 $54.30
Average True Range (ATR) 2.57 2.26
MACD 0.19 0.46
Stochastic Oscillator 60.16 95.76

Price Performance

Historical Comparison
CRSP
TREX

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About TREX Trex Company Inc.

Trex Co Inc is a manufacturer of wooden alternative decking products. The company offers outdoor products in the decking, railing, porch, fencing, trim, steel deck framing, and outdoor lighting categories. Its products are sold under the Trex brand and manufactured in the United States. Further, the company licenses its Trex brand to third parties to manufacture and sell products under the Trex trademark. The distribution is focused on wholesale distributors and retail lumber dealers, which in turn sell Trex products to homeowners and contractors, with an emphasis on professional contractors, remodelers, and homebuilders. The company operates in one reportable segment i.e. Trex Residential.

Share on Social Networks: